Md. Code Regs. 10.13.03.04

Current through Register Vol. 51, No. 22, November 1, 2024

Section 10.13.03.04 - Additional Guidelines

The Secretary may make the following additional clinical guidance available on the Department's website:

A. Any available opioid overdose reversal drug formulations, corresponding prescribing templates, and any standing order for these drugs; and

B. Any other applicable information deemed necessary by the Secretary.

Md. Code Regs. 10.13.03.04

Regulation .04 adopted effective 46:12 Md. R. 541, eff. 6/17/2019